Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover the novel synthesis of potential antiviral intermediate BL via patent CN115894498A. Offers high diastereoselectivity and scalable manufacturing for global supply chains.
Patent CN102070383A details a green Ru-catalyzed oxidation of olefins to 1,2-diketones. Offers high selectivity, broad substrate scope, and cost-effective manufacturing for pharma intermediates.
Patent CN114105875B reveals a total synthesis route for dihydroetorphine via Heck reaction. Offers cost reduction and supply stability for pharmaceutical manufacturing.
Advanced patent CN111153818A details a robust method for Oseltamivir intermediates, eliminating solidification issues and ensuring high-purity supply chain continuity.
Patent CN113461578B reveals green aqueous synthesis using ytterbium catalyst. Reduces cost and lead time for high-purity pharmaceutical intermediates and fine chemical manufacturing.
Novel synthetic route for Pramipexole Impurity C ensures high purity and operational simplicity offering significant supply chain reliability and cost reduction potential for pharmaceutical manufacturing.
Patent CN115894498A reveals a high-yield route for antiviral intermediate BL. Discover cost-effective manufacturing and scalable supply chain solutions for nucleoside analogs.
Discover the advanced synthesis of stable gingerol derivatives via aldol condensation. A cost-effective route for pharmaceutical and flavor intermediates.
Patent CN118239888A reveals a light-induced modular synthesis for high-purity acridine compounds, offering significant cost reduction and supply chain reliability for photocatalyst manufacturing.
Novel HWE reaction route for Afatinib improves purity and supply chain reliability for global pharmaceutical manufacturing partners seeking cost effective solutions.
Patent CN104003828B details a copper complex catalyzed coupling reaction under visible light, offering cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN102351870A reveals a novel benzacridine synthesis route targeting c-myc DNA, offering scalable production and cost-effective API intermediate manufacturing solutions.
Patent CN105330652B reveals improved HWE reaction for Afatinib. Enhances purity and supply reliability for global buyers seeking reliable API intermediate suppliers.
Patent CN105732521A reveals a metal-free TEMPO catalytic route for dihydroquinazolinone derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN118324765A reveals a novel Ir-catalyzed route for Duvelisib, offering cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN104045706A reveals fragment coupling for Liraglutide. Enhances purity and yield for reliable supply chain and cost reduction.
Discover the novel palladium-catalyzed intramolecular dearomatization method for indoline quinoline derivatives. Efficient one-pot synthesis for pharmaceutical intermediates.
Patent CN111574450A details novel chiral biphenyl catalysts enabling high-yield asymmetric alkylation with reduced costs and superior supply chain reliability for pharmaceutical intermediates.
Patent CN1660731A details a safe, normal-pressure ethynylation method for producing high-purity nerolidol and geranyl linalool, offering significant supply chain advantages.
Patent CN106938995B details asymmetric synthesis for bepotastine besilate. This method offers significant cost reduction and supply chain reliability for ophthalmic drug intermediate manufacturing partners.